Here is the latest shareholding Pattern of THEMIS MEDICARE. For more details, see the THEMIS MEDICARE financial fact sheet and THEMIS MEDICARE share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 57.56 | 57.56 | 57.56 | 57.55 | 57.55 | 57.55 | 57.55 | 57.54 | |
Foreign Promoters | % | 9.61 | 9.61 | 9.61 | 9.61 | 9.61 | 9.61 | 9.61 | 9.61 | |
Total Promoters | % | 67.18 | 67.18 | 67.18 | 67.16 | 67.16 | 67.16 | 67.16 | 67.15 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.02 | 0.02 | 0.06 | 0.04 | 0.05 | 0.01 | 0.03 | |
Other | % | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.01 | 0.03 | 0.03 | 0.07 | 0.05 | 0.06 | 0.02 | 0.04 | |
Bodies Corporate | % | 4.62 | 4.67 | 3.95 | 3.50 | 4.88 | 4.53 | 4.51 | 3.93 | |
Individuals | % | 22.35 | 22.32 | 23.15 | 23.12 | 22.64 | 22.32 | 22.67 | 23.31 | |
NRIs/OCBs | % | 3.05 | 3.08 | 3.08 | 3.06 | 3.05 | 3.06 | 3.08 | 3.03 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 2.79 | 2.73 | 2.61 | 3.09 | 2.22 | 2.87 | 2.56 | 2.54 | |
Total Non-Institution | % | 32.81 | 32.80 | 32.79 | 32.77 | 32.79 | 32.78 | 32.82 | 32.81 | |
Total Public | % | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 23.51 | 23.51 | 23.51 | 23.51 | 23.51 | 23.51 | 2.43 | 2.43 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.